Impact of TP53 mutations on survival outcomes in the CAR-T era of large B-cell lymphoma
{{output}}
Purpose: TP53 mutations are among the strongest adverse prognostic factors in large B-cell lymphoma (LBCL) treated with chemoimmunotherapy. Whether this unfavorable prognostic impact persists in the era of chimeric antigen recept... ...
